Sofinnova Investments’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Sofinnova Investments’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-157,172	Closed	-$3.35M	–	90
2024 Q1	$3.35M	Buy	157,172 +31,873	+25%	+$381K	0.19%	52
2023 Q4	$1.2M	Buy	125,299 +8,200	+7%	+$39.8K	0.07%	49
2023 Q3	$304K	Hold	117,099	–	–	0.02%	62
2023 Q2	$547K	Hold	117,099	–	–	0.04%	47
2023 Q1	$441K	Hold	117,099	–	–	0.03%	50
2022 Q4	$369K	Hold	117,099	–	–	0.02%	51
2022 Q3	$352K	Buy	117,099 +39,033	+50%	+$97.5K	0.02%	58
2022 Q2	$194K	Hold	78,066	–	–	0.02%	57
2022 Q1	$607K	Hold	78,066	–	–	0.05%	57
2021 Q4	$326K	Hold	78,066	–	–	0.02%	68
2021 Q3	$618K	Buy	+78,066	New	+$657K	0.04%	69

Sofinnova Investments's FUSN Position: Q2 2024 in Review

Sofinnova Investments sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 157,172 shares — an estimated $3.35M sold.

Sofinnova Investments first reported a position in FUSN in Q3 2021 and held it in 11 quarters. The position peaked at $3.35M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Sofinnova Investments reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Sofinnova Investments sold 157,172 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.35M.
Sofinnova Investments first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2021 and held it in 11 quarters.
Sofinnova Investments's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.35M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Sofinnova Investments's 13F filing for Q2 2024, filed 9 Aug 2024.